Eqis Capital Management, Inc. Glaukos Corp Transaction History
Eqis Capital Management, Inc.
- $1.15 Billion
- Q4 2024
Shares
3 transactions
Others Institutions Holding GKOS
# of Institutions
354Shares Held
50MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$1.01 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$752 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA2.16MShares$272 Million0.06% of portfolio
-
State Street Corp Boston, MA2.06MShares$260 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$243 Million0.08% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $5.99B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...